- Home
- RANI vs MPU Comparison
RANI vs MPU Comparison
Compare RANI & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- MPU
- Stock Information
- Founded
- RANI 2012
- MPU 1989
- Country
- RANI United States
- MPU Singapore
- Employees
- RANI N/A
- MPU N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- MPU Transportation Services
- Sector
- RANI Health Care
- MPU Consumer Discretionary
- Exchange
- RANI Nasdaq
- MPU Nasdaq
- Market Cap
- RANI 73.8M
- MPU 66.0M
- IPO Year
- RANI 2021
- MPU 1998
- Fundamental
- Price
- RANI $1.41
- MPU $1.71
- Analyst Decision
- RANI Strong Buy
- MPU
- Analyst Count
- RANI 5
- MPU 0
- Target Price
- RANI $11.80
- MPU N/A
- AVG Volume (30 Days)
- RANI 505.2K
- MPU 115.9K
- Earning Date
- RANI 11-14-2024
- MPU 11-12-2024
- Dividend Yield
- RANI N/A
- MPU N/A
- EPS Growth
- RANI N/A
- MPU N/A
- EPS
- RANI N/A
- MPU N/A
- Revenue
- RANI N/A
- MPU $26,001,000.00
- Revenue This Year
- RANI N/A
- MPU N/A
- Revenue Next Year
- RANI N/A
- MPU N/A
- P/E Ratio
- RANI N/A
- MPU N/A
- Revenue Growth
- RANI N/A
- MPU 1444400.00
- 52 Week Low
- RANI $1.44
- MPU $0.77
- 52 Week High
- RANI $8.75
- MPU $4.48
- Technical
- Relative Strength Index (RSI)
- RANI 25.81
- MPU 50.01
- Support Level
- RANI $1.90
- MPU $1.66
- Resistance Level
- RANI $2.00
- MPU $1.79
- Average True Range (ATR)
- RANI 0.11
- MPU 0.13
- MACD
- RANI -0.04
- MPU -0.02
- Stochastic Oscillator
- RANI 12.70
- MPU 15.63
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment.